PL3774795T3 - 4-(1h-imidazol-5-ilo)-1h-pirolo[2, 3-b]pirydyny do stosowania w leczeniu białaczki, chłoniaków i guzów litych - Google Patents
4-(1h-imidazol-5-ilo)-1h-pirolo[2, 3-b]pirydyny do stosowania w leczeniu białaczki, chłoniaków i guzów litychInfo
- Publication number
- PL3774795T3 PL3774795T3 PL19715027T PL19715027T PL3774795T3 PL 3774795 T3 PL3774795 T3 PL 3774795T3 PL 19715027 T PL19715027 T PL 19715027T PL 19715027 T PL19715027 T PL 19715027T PL 3774795 T3 PL3774795 T3 PL 3774795T3
- Authority
- PL
- Poland
- Prior art keywords
- leukaemias
- pyridines
- lymphomas
- pyrrolo
- imidazol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18164938 | 2018-03-29 | ||
PCT/EP2019/057595 WO2019185631A1 (en) | 2018-03-29 | 2019-03-26 | 4—(1h— imidazol— 5— yl) -1h-pyrrolo [2, 3-b] pyridines for use in the treatment of leukaemias, lymphomas and solid tumors |
EP19715027.9A EP3774795B1 (en) | 2018-03-29 | 2019-03-26 | 4-(1h- imidazol- 5- yl) -1h-pyrrolo [2, 3-b] pyridines for use in the treatment of leukaemias, lymphomas and solid tumors |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3774795T3 true PL3774795T3 (pl) | 2022-07-04 |
Family
ID=61837684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL19715027T PL3774795T3 (pl) | 2018-03-29 | 2019-03-26 | 4-(1h-imidazol-5-ilo)-1h-pirolo[2, 3-b]pirydyny do stosowania w leczeniu białaczki, chłoniaków i guzów litych |
Country Status (13)
Country | Link |
---|---|
US (1) | US11498920B2 (pl) |
EP (1) | EP3774795B1 (pl) |
JP (1) | JP7008967B2 (pl) |
KR (1) | KR102465111B1 (pl) |
CN (1) | CN111936496B (pl) |
AU (1) | AU2019246220B2 (pl) |
CA (1) | CA3085967C (pl) |
DK (1) | DK3774795T3 (pl) |
ES (1) | ES2918448T3 (pl) |
PL (1) | PL3774795T3 (pl) |
PT (1) | PT3774795T (pl) |
SI (1) | SI3774795T1 (pl) |
WO (1) | WO2019185631A1 (pl) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20230052017A1 (en) * | 2019-11-29 | 2023-02-16 | Facio Intellectual Property B.V. | New compounds for treatment of diseases related to DUX4 expression |
CN114315729B (zh) * | 2021-12-09 | 2024-01-26 | 大连理工大学 | 1-苄基-2,4-二芳基咪唑类化合物、合成方法及其在抗肿瘤上的应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2786424A1 (en) * | 2010-01-08 | 2011-07-14 | Ruga Corporation | Raf kinase inhibitors |
CZ2012538A3 (cs) | 2012-08-08 | 2014-02-19 | Masarykova Univerzita | Inhibitory pro léčbu B-buněčné chronické lymfocytární leukémie |
US9556179B2 (en) * | 2012-12-21 | 2017-01-31 | Bristol-Myers Squibb Company | Substituted imidazoles as casein kinase 1 D/E inhibitors |
EP3265454B1 (en) | 2015-03-02 | 2020-02-26 | Rigel Pharmaceuticals, Inc. | Tgf-beta inhibitors |
-
2019
- 2019-03-26 US US16/963,766 patent/US11498920B2/en active Active
- 2019-03-26 CA CA3085967A patent/CA3085967C/en active Active
- 2019-03-26 CN CN201980023323.3A patent/CN111936496B/zh active Active
- 2019-03-26 JP JP2020552878A patent/JP7008967B2/ja active Active
- 2019-03-26 EP EP19715027.9A patent/EP3774795B1/en active Active
- 2019-03-26 ES ES19715027T patent/ES2918448T3/es active Active
- 2019-03-26 PL PL19715027T patent/PL3774795T3/pl unknown
- 2019-03-26 PT PT197150279T patent/PT3774795T/pt unknown
- 2019-03-26 DK DK19715027.9T patent/DK3774795T3/da active
- 2019-03-26 AU AU2019246220A patent/AU2019246220B2/en active Active
- 2019-03-26 WO PCT/EP2019/057595 patent/WO2019185631A1/en active Application Filing
- 2019-03-26 SI SI201930240T patent/SI3774795T1/sl unknown
- 2019-03-26 KR KR1020207024799A patent/KR102465111B1/ko active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
AU2019246220B2 (en) | 2020-10-08 |
US20210040086A1 (en) | 2021-02-11 |
CA3085967C (en) | 2022-10-18 |
ES2918448T3 (es) | 2022-07-15 |
SI3774795T1 (sl) | 2022-07-29 |
EP3774795B1 (en) | 2022-03-16 |
KR20200116137A (ko) | 2020-10-08 |
KR102465111B1 (ko) | 2022-11-09 |
JP7008967B2 (ja) | 2022-01-25 |
CN111936496B (zh) | 2023-12-29 |
EP3774795A1 (en) | 2021-02-17 |
DK3774795T3 (da) | 2022-06-27 |
PT3774795T (pt) | 2022-07-20 |
AU2019246220A1 (en) | 2020-07-09 |
CN111936496A (zh) | 2020-11-13 |
WO2019185631A1 (en) | 2019-10-03 |
JP2021517157A (ja) | 2021-07-15 |
US11498920B2 (en) | 2022-11-15 |
CA3085967A1 (en) | 2019-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL288231A (en) | An inhibitor of jak1/2 or a pharmaceutical salt derived from it and an inhibitor of pi3k or a pharmaceutical salt derived from it, for use in the treatment of myelofibroblasts. | |
PT3838274T (pt) | Derivado de pirido[3',4':4,5]pirrolo[1,2,3-de]quinoxalina para utilização no tratamento de distúrbios do snc | |
TN2019000110A1 (en) | Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors | |
MY185392A (en) | Jak1 inhibitors for the treatment of myelodysplastic syndromes | |
IL254224B (en) | History of 5-alkyl-7-(piperidinyl/morpholinyl)-[4,2,1]triazolo[5,1-a]pyrimidine for use in medical treatment | |
IL262698B (en) | [1,2-b]Amidazo-converted pyridazines, [1,5-b]imidazo-converted pyridazines, related compounds and their use for the treatment of medical disorders | |
SG11201907095UA (en) | DERIVATIVES OF N-CYCLOALKYL/HETEROCYCLOALKYL-4-(IMIDAZO [1,2-a]PYRIDINE)PYRIMIDIN-2-AMINE AS THERAPEUTIC AGENTS | |
FI3805233T3 (fi) | N-(5-(3-hydroksipyrrolidin-1-yyli)-2-morfolinooksatsolo[4,5-b]pyridin-6-yyli)-2-(2-metylipyridin-4-yyli)okatsoli-karboksamidin (r)- (s)-enantiomeerit irak4-estäjänä syövän hoitoon | |
FI3215511T3 (fi) | Substituoituja pyratsolo(1,5-a)pyrimidiinejä ja niiden käyttö lääketieteellisten häiriöiden hoitamisessa | |
IL242170B (en) | Derivatives of 3-(2-aminopyrimidine-4yl)-5-(3-hydroxypropynyl)-h1-pyrrolo[2,3-pyridine as nickel inhibitors for cancer treatment | |
EA201590870A1 (ru) | АМИНОЗАМЕЩЕННЫЕ ИМИДАЗО[1,2-a]ПИРИДИНКАРБОКСАМИДЫ И ИХ ПРИМЕНЕНИЕ | |
EP3215509A4 (en) | Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders | |
FR2918061B1 (fr) | Derives de 6-cycloamino-3-(pyridin-4-yl)imidazo°1,2-b!- pyridazine,leur preparation et leur application en therapeutique. | |
EP3452455A4 (en) | SUBSTITUTED IMDAZO [1,2-] PYRIDINES, SUBSTITUTED IMIDAZO [1,2-] PYRAZINES, RELATED COMPOUNDS AND THEIR USE IN THE TREATMENT OF ILLNESSES | |
EP3440081A4 (en) | PYRROLO [1,2-A] PYRIMIDINYL CARBOXAMIDE COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS | |
EP3215510A4 (en) | Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical disorders | |
EP3440083A4 (en) | IMIDAZO [1,5-A] PYRIMIDINYL-CARBOXAMIDE COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDER | |
IL289164A (en) | The history of imidazo[2,1-a)pyridinyl and their use in the treatment of diseases | |
IL254155B (en) | (3s)-tetrahydro[verne-3-yl (s4)-4-isopropyl-1, 4, 6, 7-tetrahydro-5h-imidazo (4, 5-c)pyridine-5-carboxylate for use in pain treatment | |
ZA201900236B (en) | Imidazo[1,2-a]pyridine derivatives, methods for preparing the same and use thereof | |
IL275290B2 (en) | Combined treatments that include the administration of h1 - pyrazolo[4, 3-b]pyridines | |
IL275293B1 (en) | Combined treatments that include the administration of h1 - pyrazolo[4, 3-b]pyridines | |
PL3774795T3 (pl) | 4-(1h-imidazol-5-ilo)-1h-pirolo[2, 3-b]pirydyny do stosowania w leczeniu białaczki, chłoniaków i guzów litych | |
SI3452465T1 (sl) | Substituirani derivati 2,4-diamino-kinolina za uporabo v zdravljenju proliferativnih bolezni | |
WO2018094106A3 (en) | ALLOSTERIC ANTAGONISTS OF GPRC6a AND THEIR USE IN MITIGATING PROTEINOPATHIES |